Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus

Openshaw Peter; MacIntyre-Cockett George; Bont Louis; Öner Deniz; Aerssens Jeroen; Nair Harish; Pollard Andrew J.; O’Connor Daniel; Butler Christopher; Snape Matthew D.; Ansari M. Azim; Drysdale Simon B.; de Cesare Mariateresa; Bowden Rory; RESCEU Investigators; Brown Anthony; Golubchik Tanya; Bonsall David; Mellado-Gomez Esther; Martinón-Torres Federico; Lin Gu-Lung

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus

Openshaw Peter
MacIntyre-Cockett George
Bont Louis
Öner Deniz
Aerssens Jeroen
Nair Harish
Pollard Andrew J.
O’Connor Daniel
Butler Christopher
Snape Matthew D.
Ansari M. Azim
Drysdale Simon B.
de Cesare Mariateresa
Bowden Rory; RESCEU Investigators
Brown Anthony
Golubchik Tanya
Bonsall David
Mellado-Gomez Esther
Martinón-Torres Federico
Lin Gu-Lung
Katso/Avaa
Publisher's PDF (2.902Mb)
Lataukset: 

Nature Research
doi:10.1038/s41467-021-25265-4
URI
https://www.nature.com/articles/s41467-021-25265-4
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021102752573
Tiivistelmä

Human respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection in young children globally, but little is known about within-host RSV diversity. Here, we characterised within-host RSV populations using deep-sequencing data from 319 nasopharyngeal swabs collected during 2017–2020. RSV-B had lower consensus diversity than RSV-A at the population level, while exhibiting greater within-host diversity. Two RSV-B consensus sequences had an amino acid alteration (K68N) in the fusion (F) protein, which has been associated with reduced susceptibility to nirsevimab (MEDI8897), a novel RSV monoclonal antibody under development. In addition, several minor variants were identified in the antigenic sites of the F protein, one of which may confer resistance to palivizumab, the only licensed RSV monoclonal antibody. The differences in within-host virus populations emphasise the importance of monitoring for vaccine efficacy and may help to explain the different prevalences of monoclonal antibody-escape mutants between the two subgroups.

Kokoelmat
  • Rinnakkaistallenteet [19207]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste